Loading …

Featured News

Baltimore’s Gemstone Biotherapeutics Poised to Transform Wound Care Market

Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1)

Inaugural Investment Conference Marks Inflection Point for the BioHealth Capital Region

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology

New Technology Impacting Immune-Oncology Research Attracts National Audience at First Annual Bio-Trac Symposium

Published on : 3 Oct 2018
Published by : Gina Hagler

Four Companies Using Big Data to Drive Innovation in Precision Medicine: A Recap of the 1st Digital Omics Innovators Meetup

Published on : 25 Sep 2018
Published by : Joelle Herman

Virginia Life Science Industry Leaders Gather for Workforce Summit

Published on : 23 Jun 2018
Published by : Chris Frew

GSK’s Head of Global Recruitment goes live on facebook – Sept 28th

$2.5 Million Grant Awarded to BioHealth Capital Region Research Collaborative to Fight Deadly Virus

BioTalk Podcast Energized by Jeff Galvin, CEO of American Gene Technologies

In Conversation

Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1)

Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1)

Published on : 9 Oct 2018
Published by : Chris Frew

Q&A With BeneVir Co-Founder and COO, Katherine Sacksteder, PhD - The Path to a Landmark Acquisition (Part 1) October 9, 2018 This has been a year marked by many notable biotech deals, especially in the immunotherapy market.  One deal, in particular,

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology

Published on : 8 Oct 2018
Published by : Chris Frew

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology October 8, 2018 Abhita Batra, CEO Otomagnetics, Inc., is leading the growth of an innovative biotech startup, and bringing a drug delivery

Q&A with Immunomic’s Teri Heiland, PhD: What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy

Q&A with Immunomic’s Teri Heiland, PhD: What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy

“In Conversation” with Mina Izadjoo, President of IPS

“In Conversation” with Mina Izadjoo, President of IPS

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

Aaron Chang, Renalert CEO – Engineering a Global Paradigm Shift to Prevent Acute Kidney Injury

Aaron Chang, Renalert CEO – Engineering a Global Paradigm Shift to Prevent Acute Kidney Injury

Regional Spotlight

Featured Regional Spotlight

Paragon Welcomes Employees to New 151,000 sq/ft Gene Therapy Manufacturing Facility

Published by : Chris Frew
Published on : 31 Jul 2018
Featured Regional Spotlight

These Philosophies Have Propelled The Emmes Corporation to Become a Leading International Clinical Research Organization

Published by : Chris Frew
Published on : 30 Jul 2018
Regional Spotlight

Recap: Virginia Drug Discovery Rx: Symposium on Academic-Industrial Partnerships in Drug Discovery

Published by : Chris Frew
Published on : 1 Jul 2018

building a more connected biotech ecosystem

Categories